Webinar – Hit Identification
MDC Connects is a series of informative webinars covering the drug discovery process, from our own experts and experts at our CRO network partners. The identification of high quality leads is an important step in the discovery of a new drug, but in order to achieve a relevant starting point there are several factors to […]
Webinar – Identifying the Target
MDC Connects is a series of informative webinars covering the drug discovery process, from our own experts and experts at our CRO network partners. Lack of efficacy is one of the most important causes of failure in clinical trials. Therefore identifying the biological target for a drug discovery project is one of the most important […]
Webinar – Turning Molecules into Medicines
In this webinar, Gayle Marshall, Lead Scientist for Biomarkers, covers why drugs fail in the clinic and how to acquire critical information to inform confidence for clinical success. Gayle discusses how we can aid decision making from the pre-clinical to the clinical setting, supporting line of sight to the clinic, by identifying and translating crucial biomarker approaches […]
Webinar – Psychiatry Consortium first call for proposals
In this webinar Alessandra Gaeta, Programme Director, Syndicates, talks through the Psychiatry Consortium first call for proposals – including scope, eligibility and detail on the funding model. Recording Find out more about the Psychiatry Consortium >
Webinar – Imaging technologies to visualise drug discovery
Imaging allows a non-invasive assessment of biochemical and biological processes in a living subject. Monitoring, assessing, and characterising novel therapeutics in pre-clinical models is an essential part of drug development. In this webinar Dr Juliana Maynard, Lead Scientist in Pre-clinical Imaging, and Dr Philippa Hart, Lead Scientist in Mass Spectrometry Imaging, explore available imaging technologies […]
Webinar – State of the Discovery Nation 2019
In association with the BioIndustry Association (BIA), we have conducted our second review of the State of the Discovery Nation. This year, the report reviews the size and shape of the sector, and then focusses on two technology areas that are set to influence the future of Medicines Discovery: Complex (pre-clinical) cell models (CCMs) Artificial […]